This Article Full Text Full Text (PDF) All Versions of this Article: 91/7/2490    most recent Author Manuscript (PDF) Submit a related Letter to the Editor Purchase Article View Shopping Cart Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Kung, A. W. C. Search for Related Content PubMed PubMed Citation Articles by Kung, A. W. C. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Medline Plus Health Information Muscle Disorders Paralysis Hazardous Substances DB POTASSIUM POTASSIUM CHLORIDE Related Collections Thyroid Metabolism

Thyrotoxic Periodic Paralysis: A Diagnostic Challenge

Department of Medicine, The University of Hong Kong, Queen Mary Hospital, Hong Kong, China

Address all correspondence and requests for reprints to: Annie W. C. Kung, Department of Medicine, The University of Hong Kong, Queen Mary Hospital, Hong Kong, China. E-mail: awckung{at}hkucc.hku.hk.

Context: The aim of this article was to review the clinical presentation, pathogenesis, and management of thyrotoxic periodic paralysis (TPP).

Evidence Acquisition: A MEDLINE search was conducted for articles published during the last 40 yr based on the key words thyrotoxic periodic paralysis and hypokalemic periodic paralysis. A total of 281 primary articles and 168 references of the retrieved articles were also reviewed.

Evidence Synthesis: TPP is a common complication of hyperthyroidism in Asian men but is increasingly seen in Western countries. Hypokalemia and muscle paralysis results from a sudden intracellular shift of potassium and is not due to potassium deficiency. Clinical features of hyperthyroidism in patients with TPP may be subtle. Immediate potassium supplementation prevents serious cardiopulmonary complications and may hasten the recovery of muscle weakness. Nonselective ß-adrenergic blockers can ameliorate and prevent recurrence of the paralytic attacks. This episodic paralysis will remit with definitive control of hyperthyroidism. Increased sodium-potassium ATPase pump activity and enhanced insulin response in patients with TPP is postulated to contribute to the hypokalemia. The genetic predisposition for TPP is not entirely clear. Association of polymorphisms of the calcium channel 1-subunit gene with TPP has been noted.

Conclusions: Due to population mobility, TPP is increasingly common in Western countries. Early diagnosis and prompt treatment prevent life-threatening complications associated with hypokalemia and muscle weakness. Assaying of thyroid function in patients with hypokalemic paralysis distinguishes TPP from other forms of hypokalemic periodic paralysis.

This article has been cited by other articles:

				F. Vendrame, A. Verrienti, C. Parlapiano, S. Filetti, F. Dotta, and S. Morano Thyrotoxic periodic paralysis in an Italian man: clinical manifestation and genetic analysis Ann Clin Biochem, March 1, 2008; 45(2): 218 - 220. [Abstract] [Full Text] [PDF]

				M. Connor Immune or not immune: two cases of acute flaccid motor paralysis Practical Neurology, November 1, 2007; 7(6): 412 - 415. [Full Text] [PDF]

				Z. D. Goldberger An Electrocardiogram Triad in Thyrotoxic Hypokalemic Periodic Paralysis Circulation, February 13, 2007; 115(6): e179 - e180. [Full Text] [PDF]